OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
Webinar on Verified Antigen
Verified Antigen Webinar

Browse all lysates


spacer
OriGene in recent publications
Calpain-2-Mediated PTEN Degradation Contributes to BDNF-Induced Stimulation of Dendritic Protein Synthesis J. Neurosci., Mar 2013; 33: 4317 - 4328. [CAPN2]

Screening Citrullinated Proteins in Synovial Tissues of Rheumatoid Arthritis Using 2-dimensional Western Blotting J Rheumatol, Mar 2013; 40: 219 - 227. [TUBB]

Lysyl Oxidase Plays a Critical Role in Endothelial Cell Stimulation to Drive Tumor Angiogenesis Cancer Res., Jan 2013; 73: 583 - 594. [Lox]

Tissue-specific control of brain-enriched miR-7 biogenesis Genes & Dev., Jan 2013; 27: 24 - 38. [ELAVL1 ]

View All Citations >>

spacer

134 Lysate belong to pathway "colorectal cancer"

divider

  Page: 1 of 7 
Direct Download
spacer
SKUAccnSymbolDescriptionShipping
LY400094NM_000245METTransient overexpression lysate of met proto-oncogene (hepatocyte growth factor receptor) (MET), transcript variant 2 5 days
LY400096NM_000249MLH1Transient overexpression lysate of mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 1 5 days
LY400186NM_000546TP53Transient overexpression lysate of tumor protein p53 (TP53), transcript variant 1 5 days
LY400311NM_000875IGF1RTransient overexpression lysate of insulin-like growth factor 1 receptor (IGF1R) 5 days
LY400372NM_001003652SMAD2Transient overexpression lysate of SMAD family member 2 (SMAD2), transcript variant 2 5 days
LY400469NM_001168BIRC5Transient overexpression lysate of baculoviral IAP repeat-containing 5 (BIRC5), transcript variant 1 5 days
LY400491NM_001229CASP9Transient overexpression lysate of caspase 9, apoptosis-related cysteine peptidase (CASP9), transcript variant alpha 5 days
LY400765NM_002086GRB2Transient overexpression lysate of growth factor receptor-bound protein 2 (GRB2), transcript variant 1 5 days
LY400825NM_002228JUNTransient overexpression lysate of jun oncogene (JUN) 5 days
LY400876NM_002467MYCTransient overexpression lysate of v-myc myelocytomatosis viral oncogene homolog (avian) (MYC) 5 days
LY400921NM_002609PDGFRBTransient overexpression lysate of platelet-derived growth factor receptor, beta polypeptide (PDGFRB) 5 days
LY400968NM_002746MAPK3Transient overexpression lysate of mitogen-activated protein kinase 3 (MAPK3), transcript variant 1 5 days
LY400970NM_002750MAPK8Transient overexpression lysate of mitogen-activated protein kinase 8 (MAPK8), transcript variant JNK1-a1 5 days
LY400972NM_002752MAPK9Transient overexpression lysate of mitogen-activated protein kinase 9 (MAPK9), transcript variant JNK2-a2 5 days
LY400974NM_002755MAP2K1Transient overexpression lysate of mitogen-activated protein kinase kinase 1 (MAP2K1) 5 days
LY401115NM_003238TGFB2Transient overexpression lysate of transforming growth factor, beta 2 (TGFB2), transcript variant 2 5 days
LY401116NM_003242TGFBR2Transient overexpression lysate of transforming growth factor, beta receptor II (70/80kDa) (TGFBR2), transcript variant 2 5 days
LY401175NM_003468FZD5Transient overexpression lysate of frizzled homolog 5 (Drosophila) (FZD5) 5 days
LY401182NM_003506FZD6Transient overexpression lysate of frizzled homolog 6 (Drosophila) (FZD6), transcript variant 1 5 days
LY401202NM_003629PIK3R3Transient overexpression lysate of phosphoinositide-3-kinase, regulatory subunit 3 (gamma) (PIK3R3), transcript variant 1 5 days

 

pattern
Inc 5000 Healthcare Company Copyright © 2013 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.

All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title